Theme: To safeguard public health
Infection Control 2017
With the grand success from the previous relevant annual International conferences, ConferenceSeries Ltd is organizing “Infection Control & Prevention” (Infection Control 2017) scheduled during September 25-26, 2017 in Chicago, USA. Infection Control 2017 brings together the global leaders in infection control and relevant fields to present their research at this exclusive scientific program.
The Infection Control and Prevention conference hosting presentations from editors of eminent refereed journals, renowned and active investigators and decision makers in the field of infectious diseases, microbiology, immunology, infection control and prevention. Infection control 2017 Organizing Committee also invites young investigators at each and every career stage to submit abstracts reporting their latest scientific researches in oral and poster sessions.
Infection control and prevention is required to prevent the transmission of communicable diseases in all health care settings. Infection control and prevention demands a basic understanding of the epidemiology of diseases; risk factors that increase patient susceptibility to infection; and the practices, procedures and treatments that may result in infections. the risk of acquiring a healthcare-associated infection is related to the mode of transmission of the infectious agent (e.g. CRE, CDI, MRSA, SSI, etc.) and the type of patient-care activity or procedure being performed and the underlying patient’s host defences.
When we look at the worldwide deaths due to Infectious Diseases the conference get significance on some diseases like Tetanus (500,000), measles (1 million), Malaria (2.1million), hepatitis b (1.1million), diarrhoea (3.1 million), tuberculosis (3.1 million), HIV/AIDS (1 million) and respiratory Infections (4.4 million).
Who should attend?
• Health Care Professionals
• Infectious Diseases Specialists
• Infection Prevention and Infection Control Specialists
Why to attend?
With members from all over the world concentrated on learning about global trends on emerging infectious diseases and it promotes in therapeutic and diagnostic market, this is your finest chance to reach the largest accumulation of participants from the Infectious diseases community. This particular conference Infection Control and Prevention conduct presentations, distributes information, conducts meetings with current and prospective scientists, make a splash with new drug developments, and receive name recollection at this 2 days event. World distinguished speakers, the most recent therapeutic and diagnostic techniques, developments of Novel technologies and therapeutic measures for infectious diseases prevention and treatment are the authentication marks of this conference.
• Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
• Infectious Diseases Researchers, Scientists, Faculties, Students
• Infectious Diseases Associations and Societies
• Medical Colleges
• Pharmaceutical Companies and Industries
• Medical Devices Manufacturing Companies
• Drug Manufacturing Companies and Industries
• Laboratory Technicians and Diagnostic Companies
• Business Entrepreneurs and Industrialists
• Training Institutes
• Software Developing Companies
• Data Management Companies
For Scientific Sessions please go through the link:
For Abstract Submission please go through the link:
Track 1: Infection Treatment and Prevention Control
The infections which are caused by germs and may infect any part of the body are called infectious diseases. The diseases can be spread, directly or indirectly, from one person to another by microorganisms such as bacteria, viruses, parasites or fungi . Infection prevention and control is helpful to prevent the transmission of infectious diseases from one to one. Infections can also be controlled and prevented by creating awareness on various infectious diseases and their outbreaks in public. Recent techniques have demonstrated that there is no disease that cannot be treated. Diseases such as cancer can be prevented by chemotherapy.
Track 2: Infection Novel Therapies
Infectious Diseases and Infection Therapy is of high-quality preclinical, observational, clinical, real-world, and health outcomes research around the discovery, development, and use of infectious disease interventions and therapies, including vaccines and devices. Studies relating to diagnostic products and diagnosis, public health, pharmacoeconomics, quality of life, patient care, management, and education are also encouraged. CAGR for Infection Control in Cancer therapy is composed to grow around 15.5% over the forecast period 2015 to 2025.
Track 3: Surveillance Practice for MRSA
MRSA has become one of the main pathogens in health-related infections. Treatment options for MRSA are limited and less effective than those available for susceptible S. aureus infections, and lead to higher levels of morbidity and mortality. Hospitals are discussing whether each patient should receive a smear when injecting methicillin-resistant Staphylococcus aureus or simply every patient entering the intensive care unit or just certain groups of patients, for example, undergoing dialysis or those who are in pediatric practice. Current estimates suggest that 49-65% of the health-associated infections of S. aureus reported in the NHSN are caused by methicillin-resistant strains.
Track 4: Infection Control in Intravenous Therapy/Physical Therapy
The introduction, maintenance and monitoring of intravenous systems require close attention by both doctors and nurses. Improvements are needed. Only by joint efforts of all stakeholders will the risk of intravenous therapy be reduced. The World Confederation of Physiotherapy (WCPT) advocates that the prevention and control of infections is the responsibility of all persons involved in the provision of health services and should be included in daily practice.This applies to infections acquired by health services and to those resulting from other sources, not just those considered high risk infectious diseases. Early diagnosis along with management strategies and containment of infections is important for the well-being of patients / clients and all health professionals.
Track 5: Resistance and Emerging Infectious Organisms
The emerging antimicrobial resistance among hospital pathogens, as a rule, becomes endemic, but some outbreaks are grouped. Detailed descriptions of microbes and epidemiology of pathogens by reference laboratories, such as the WRAIR Multi-Drug Resistance and Surveillance Network (MRSN), are well described.
Infectious disease, the occurrence of which in recent years has increased or threatens to increase, is called emerging. These diseases include new infections, previously unrecognized infections and old infections that result from antimicrobial resistance, public health problems and unsanitary conditions.
Track 6: Control of Organs Transplatantation Infection
Since complications from infection are the main cause of morbidity and mortality after transplantation, infection prevention is the cornerstone of any modern solid organ transplantation program. This topic is not a thorough analysis of all studies devoted to the prevention of infection after organ transplantation but is a practical guide to common recommendations for the prevention of common infections in transplant conditions such as bacterial infections, including tuberculosis, cytomegalovirus, hepatitis viruses or invasive fungal infections.
Track 7: Hepatitis C Virus
Hepatitis C is an inflammation of the liver caused by an infection with the hepatitis C virus (HCV). The pathogen is mainly transmitted through the blood. The HCV virus is also detectable in other body fluids such as sperm and breast milk, but transmission through it is extremely rare. The virus is an RNA virus and belongs to the flavivirus family. It exists in many different subforms (six genotypes and 30 serotypes) and is transmitted primarily through the blood.
Track 8: Food and Drug Administration
The FDA is famous for its work on regulating the development of new drugs. The FDA has developed rules regarding clinical trials that must be performed for all new medicines. At present, pharmaceutical companies need to test drugs through four phases of clinical trials before they can be sold to individuals. Repeated submission of failed applications is costly, delaying marketing approval and the availability of new medicines for patients. A full analysis of the economic consequences of significant provisions of the FDA is no longer published in the Federal Register, but is available on this website..
Track 9: Pediatric Infections Prevention and Control
Pediatric infections / infections in children are infections that occur in children of different age groups. The specialist in pediatric infections cares for infections that occur in children, and the methods of treatment vary among children from adults. 11 million children die each year as a result of six causes: diarrhea, malaria, neonatal infection, pneumonia, premature birth or lack of oxygen at birth. Some of the deaths come from diseases such as measles, malaria or tetanus. Others are indirectly linked to marginalization, conflict and HIV / AIDS. Every year, the global burden of child mortality increases dramatically.
Track 10: Infection Control Products/Infection Rates
Consistency and orderly processes are crucial for the control and prevention of infections. Decisions to reduce hospital infections should be intuitive, effective and easily implemented. Our portfolio for the prevention of infection includes products intended for the treatment of urinary tract infections associated with catheter (CAUTI), infections caused by central blood flow (CLABSI), surgical infections in situ (SSI), prevention of pneumonia (HAP and VAP) and Disinfection of surfaces. The frequency of infection is often calculated by dividing the number of infections received during the month by the number of patients discharged during this month. Based on the indicator of the number of infections per patient per day, you can check for inter-hospital and intra-hospital differences, as well as differences in time.
Track 11: Influenza Related Illness/Influenza Virus
The vaccine against influenza is less effective in the elderly. It is not known whether vaccination against influenza brings ageless adults additional protection from illness among the elderly. In a large, nationwide sample of Medicare recipients, influenza vaccination among adults aged 18-64 was inversely associated with influenza-related illness in the elderly. This year the world market of products used in the fight against influenza is estimated at 5.5 billion dollars. USA, according to a new research report on market research of the Global Influenza Market from BCC Research. It is expected that market revenues will increase with a five-year average annual growth rate (CAGR) of 8% from 2013 to 2018 and will amount to nearly $ 6 billion in 2018.
Track 12: Smallpox/ Chickenpox Infection Control
Smallpox is a serious, infectious and sometimes fatal infectious disease. There is no proven treatment for smallpox disease. Prophylaxis is achieved by vaccination. Smallpox vaccines and antiviral drugs can be used to combat the smallpox epidemic. Chikungunya is a febrile infection that resembles dengue fever, which is found especially in parts of Africa, India and Southeast Asia, caused by the virus of the genus aphavirus (the chikungun virus of the genus) and transmitted by mosquitoes, especially those belonging to the genus aedes.
Track 13: Fungal Infections/Germs
Infections caused by microbes and which can infect any part of the body are called infectious diseases. They can be spread by any means where there is an embryo. They are caused by pathogenic microorganisms, such as bacteria, virus, parasites and fungi. Microbes can spread directly or indirectly. Vaccination, maintenance of proper hygiene and medication help in preventing infection. It is expected that the market for infection control in cancer therapy will have huge growth potential in the next few years. In addition, growing public awareness of health and poor sanitation in underdeveloped countries are even more likely to increase the market.
Track 14: Rabies/Ebola Viral Infections Control
Rabies is an infectious viral disease that almost always leads to death after the appearance of clinical signs. In up to 99% of human cases, rabies virus is transmitted by domestic dogs. Rabies affects domestic and wild animals and spreads among people through bites or scratches, usually through saliva. . Ebola virus infection is caused by a virus transmitted through biological fluids and through the air. This happens rarely, but it is very lethal, which leads to death and outbreak. Symptoms of viral Ebola disease are very severe, which appear after 2-3 days. The main symptoms of ebola are fever, sore throat, muscle pain and headaches accompanied by vomiting, diarrhea, rash, reduced liver and kidney function, and then loss of blood from the inside and out, which ultimately leads to low blood pressure and loss of fluid, Leading to death.
Track 15: Control of Infections during Pregnancy
Infections in mother can sometimes lead to birth defects in her unborn child. Maintaining proper hygiene and taking several additional precautions can sometimes mean the difference between a healthy, happy child and a life-threatening disease. The use of intermittent prophylactic treatment during pregnancy and the use of networks led to the prevention of 94 000 deaths from newborns in 25 African countries between 2009 and 2012. If these interventions were applied to 80% of the population at risk, an estimated 300,000 deaths could be prevented.
Track 16: Infection by Zoonosis
Animal / zoonotic infections pose a serious threat to human health, since zoonotic pathogens predominate when human diseases occur. Infectious diseases affect livestock, as well as wild animals, focused on characterizing the conditions of spread of pathogens and their maintenance in the host population. The scientist's assessment of zoonotic diseases is that more than 8 out of every 12 known infectious diseases in humans spread from fauna, and 4 out of every 5 new or emerging infectious diseases in humans spread from fauna. Annually, it is estimated that thousands of Americans suffer from diseases spread between faunas and humans. Because of this, the national health agency works 24/7 to protect people from zoonotic diseases.
Track 17: Practices and Awareness of Infection Control
Public awareness refers to the important role that the enthusiasm and knowledge of the community have in building viable societies. Transferring knowledge to remote communities requires strategies for effective communication with regard to prevention and control of infections and the maintenance of adequate hygiene by creating a healthy environment and an infection-free world. The growing aging population associated with the increase in the incidence of chronic diseases has also led to an increase in demand for products to fight infection. However, factors such as stringent regulatory requirements and the need to comply with them may to a certain extent inhibit the growth of the market for infection control.
Track 18: Surgical Infections Control
Surgical infections provide comprehensive and authoritative information on the biology, prevention and treatment of postoperative infections. The original articles cover the latest achievements, new therapeutic management strategies and translational research that are used to improve clinical outcomes and the successful treatment of postoperative infections. The market for global surgical and infectious devices has grown significantly over the past five years and is expected to continue to grow, reaching around 84 billion dollars in 2017. The CAGR will be 6.6% over the next five years.
Track 19: Respiratory and Pulmonary Infections Prevention and Control
Respiratory infections are infections that occur in the airways, and are further classified as upper respiratory tract infections and lower respiratory tract infections. Pulmonary infections are mainly observed in the lungs, which in turn causes acute bronchitis or pneumonia, which are often caused by viruses, but can also be caused by bacteria or fungal organisms. In patients with COPD who require intubation and invasive MV for hypercapnic respiratory failure, which is exacerbated by pulmonary infection, early extubation, accompanied by a non-invasive MV initiated at the start of the PIC window, can significantly reduce the duration of invasive MV, the risk of VAP and hospital mortality.
Track 20: Control of Zika/Malaria/Dengue Viral Infections
Viral infection Zika is caused by a virus transmitted predominantly by mosquitoes Aed. People with viral zik infection may have symptoms, including mild fever, skin rash, conjunctivitis, muscle and joint pain, general malaise or headache. Malaria is an infection carried by mosquitoes that infects humans and other animals caused by parasitic protozoa (a group of unicellular microorganisms) belonging to the plasmodium type. Malaria symptoms usually include fever, fatigue, vomiting and headaches, which can be observed at 10-15 after a mosquito bite. In severe cases, it can cause yellow skin, cramps, coma and even death. Dengue fever is a debilitating viral infection of the tropics transmitted by mosquitoes, which in turn cause sudden fever and acute pains in the joints.
Track 21: Disinfecting with UV Technology
UV disinfection is effective at wavelengths from 200 to 300 nm. Emitted UVC radiation has a strong bactericidal effect. It is absorbed by DNA, destroys its structure and inactivates living cells. Microorganisms, such as viruses, bacteria, yeasts and fungi, become harmless for a few seconds due to UV radiation. If the irradiation is sufficiently high, UV disinfection is a reliable and environmentally safe method, since chemicals need not be added. In addition, microorganisms can not become resistant to UV radiation.
Track 22: Control of HIV/AIDS from STDs & STIs
Infection of the human immunodeficiency virus and acquired immunodeficiency syndrome (HIV / AIDS) is a spectrum of conditions caused by infection with the human immunodeficiency virus (HIV). Sexually transmitted infections / sexually transmitted infections are sexually transmitted infections with an infected person, as well as those transmitted during vaginal or other types of sexual intercourse, including oral and anal sex. In many countries, basic STI services are in disarray, since program resources are determined by decisions pertaining to one subject of the disease. Major HIV epidemics have emerged and rapidly spread in the face of poor STI control, and further weakening of STI control can undermine other HIV prevention efforts.
Track 23: Infection Control from Plants
Diseases of plants caused serious human losses in several ways. Starvation and uprooting of families occurred as a result of the Irish famine caused by potato late blight. The estimated resource was lost with the actual destruction of American chestnut due to chestnut infection (caused by Cryphonectria parasitica). And direct economic losses, such as an estimated one billion dollars lost in one year to American corn producers from the bushes of southern corn leaves. Many plant diseases cause less severe losses around the world every year, but together they represent significant losses for farmers and can reduce aesthetic values of landscape plants and home gardens.
Infection Control & Prevention Therapeutic Market
The global market for the treatment of infectious diseases in 2009 was estimated at $90.4 billion USA. It is expected that this market will increase with the cumulative annual growth rate (CAGR) by 8.8% to reach $138 billion in 2014. The largest share of the market belongs to antibiotics for bacterial and fungal diseases, 53% of the total market for the treatment of infectious diseases. Treatment of fungal diseases will be characterized by a slightly higher average annual growth rate (CAGR) of 6.2%, from $4.6 billion 2009 to $6.2 billion in 2014. Treatment of viral diseases will have the fastest aggregate annual growth rate (CAGR) of 12.1%. Almost $45 billion 2009 to $79 billion in 2014.
Infection Control & Prevention Market worth 17.78 Billion USD by 2021
It is estimated that in 2014-2019. The market for therapeutic infectious diseases in the US will grow by 3.37%. According to the data, 25% of deaths occur mainly due to infectious diseases all over the world. The current market trend shows that North America. In Asia, the highest global market in Asia is expected, followed by Europe in the global market for the treatment of infectious diseases. . The main reasons underlying the world's highest market for therapeutic agents for the treatment of infectious diseases in the countries mentioned above are mainly due to the large number of patients and increased government funding. The market for tests of molecular diagnostics of infectious diseases includes hospitals, blood banks, reference laboratories. The report "Market of infection control through disinfection (disinfectants, disinfectants, endoscopes, reprograms, napkins, face masks) Sterilization (steam sterilization, ethylene oxide, VHP, electron beam, contract services) End user (hospitals, life experience) - global forecast to 2021 Year, Analyzes and studies the main market factors, constraints and opportunities in North America, Europe, the Asia-Pacific region, Latin America, the Middle East and Africa in the coming years.
Chicago is the third most populous city in the US state of Illinois, and in the American Midwest with an average population of about 2.7 million people. . The city is located within the humid continental climatic zone and with seasonal changes. The city is an international center for finance, trade, industry, technology, telecommunications and transport. Chicago was included in the global alpha center in the network of studies of globalization and world cities. Institutions in and around Chicago are consistently among the best "national universities", some of the higher education institutions in Chicago include the Northwestern University; University of Chicago; Illinois Institute of Technology; University of Loyola in Chicago; And the University of Illinois in Chicago. Some schools include: the Chicago State University; University of the Northern Park; Columbia College of Chicago; North-eastern University of Illinois; The University of Roosevelt; St. Xavier University; And Rush University. In Chicago and in the vicinity of Chicago, there are many opportunities for research exclusively in the fields of science and technology and in the field of medicine. Also in the field of banking and finance. Scientists from leading universities contribute to world-class research through the Chicago conferences, seminars and symposiums in which professionals from business take part in the "Great Spirit" and give glory to the meetings and seminars organized by Conference Series LLc.
Members Associated with Infection Control & Prevention
- Infection Prevention Society around 2,000 members
- The Association for Professionals in Infection Control and Epidemiology (APIC) is the leading professional association for infection preventionists (IPs) with more than 15,000 members
- LSHTM_Control of Infectious Diseases has 19 members
- Global Public Health is having 106913 members
Societies and Associations related to Infection Control
- Association for Professionals in Infection Control and Epidemiology (APIC)
- Asia Pacific Society of Infection Control (APSIC)
- Ho Chi Minh Society of Infection Control (Vietnam)
- Indonesian Society of Infection Control
- Korean Society of Nosocomial Infection Control(KOSNIC)
- Sri Lanka Infection Control Nurses Association
- Taiwan Infection Control Society (ICST)
- The Infectious Diseases Society of Taiwan (IDST)
- Borneo Malaysia Infection Control and Antimicrobial Society Kota Kinabalu,
- Infection Control Association of Singapore
- Australasian College of Infection Prevention and Control (ACIPC)
- Malaysia Infection Control Association
- Hong Kong Infection Control Nurses Association (HKICNA)
Universities related to Infection Control
- University of Illinios-Chicago
- University of Toledo
- University of south Florido
- University of California, Berkerly
- Drexel University
- Colombia University, New York
- University of Washington
- Texas A&M Health Science Centre
- Tulane University
- Loma Linda University
- University of Minnesota-Twin Cities
- University of South Carolina
- Rutgers University-New Jersy
- University of Arizona
- Infection Treatment and Prevention Control
- Infection Novel Therapies
- Surveillance Practice for MRSA
- Infection Control in Intravenous Therapy/Physical Therapy
- Resistance and Emerging Infectious Organisms
- Control of Organs Transplatantation Infection
- Food and Drug Administration
- Pediatric Infections Prevention and Control
- Infection Control Products/Infection Rates
- Influenza Related Illness/Influenza Virus
- Smallpox/ Chickenpox Infection Control
- Fungal Infections/Germs
- Rabies/Ebola Viral Infections Control
- Control of Infections during Pregnancy
- Infection by Zoonosis
- Practices and Awareness of Infection Control
- Surgical Infections Control
- Respiratory and Pulmonary Infections Prevention and Control
- Control of Zika/Malaria/Dengue Viral Infections
- Disinfecting with UV Technology
- Control of HIV/AIDS from STDs & STIs
- Infection control from Plants
- Hepatitis C
To share your views and research, please click here to register for the Conference.